Colorectal cancer screening. Crossing the threshold

Research output: Contribution to journalArticle

Abstract

Colorectal cancer remains a major cause of cancer mortality in the United States, Europe and Australia. Recently, significant advances in our understanding of the molecular basis of colorectal cancer have been made. These advances have been complemented by the results of several large studies which have demonstrated decreased colorectal cancer mortality by the use of conventional screening tests, including the fecal occult blood test and sigmoidoscopy. Taken together, these developments have added powerful weapons for today's clinician in combating large bowel cancer. In this paper, screening techniques for average and high-risk groups for colorectal cancer will be reviewed. We have crossed the threshold and have entered the era in which colorectal cancer will be increasingly diagnosed in the asymptomatic, at-risk population with a resultant decreased morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)32-45
Number of pages14
JournalGastroenterology International
Volume10
Issue number1
StatePublished - Jan 1 1997

Fingerprint

Early Detection of Cancer
Colorectal Neoplasms
Mortality
Sigmoidoscopy
Occult Blood
Weapons
Hematologic Tests
Colonic Neoplasms
Morbidity
Neoplasms

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

@article{f4e48d5bc3344e4aab7991854acee8f5,
title = "Colorectal cancer screening. Crossing the threshold",
abstract = "Colorectal cancer remains a major cause of cancer mortality in the United States, Europe and Australia. Recently, significant advances in our understanding of the molecular basis of colorectal cancer have been made. These advances have been complemented by the results of several large studies which have demonstrated decreased colorectal cancer mortality by the use of conventional screening tests, including the fecal occult blood test and sigmoidoscopy. Taken together, these developments have added powerful weapons for today's clinician in combating large bowel cancer. In this paper, screening techniques for average and high-risk groups for colorectal cancer will be reviewed. We have crossed the threshold and have entered the era in which colorectal cancer will be increasingly diagnosed in the asymptomatic, at-risk population with a resultant decreased morbidity and mortality.",
author = "Thomas McGarrity",
year = "1997",
month = "1",
day = "1",
language = "English (US)",
volume = "10",
pages = "32--45",
journal = "Gastroenterology International",
issn = "0950-5911",
publisher = "International Universities Press Inc.",
number = "1",

}

Colorectal cancer screening. Crossing the threshold. / McGarrity, Thomas.

In: Gastroenterology International, Vol. 10, No. 1, 01.01.1997, p. 32-45.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Colorectal cancer screening. Crossing the threshold

AU - McGarrity, Thomas

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Colorectal cancer remains a major cause of cancer mortality in the United States, Europe and Australia. Recently, significant advances in our understanding of the molecular basis of colorectal cancer have been made. These advances have been complemented by the results of several large studies which have demonstrated decreased colorectal cancer mortality by the use of conventional screening tests, including the fecal occult blood test and sigmoidoscopy. Taken together, these developments have added powerful weapons for today's clinician in combating large bowel cancer. In this paper, screening techniques for average and high-risk groups for colorectal cancer will be reviewed. We have crossed the threshold and have entered the era in which colorectal cancer will be increasingly diagnosed in the asymptomatic, at-risk population with a resultant decreased morbidity and mortality.

AB - Colorectal cancer remains a major cause of cancer mortality in the United States, Europe and Australia. Recently, significant advances in our understanding of the molecular basis of colorectal cancer have been made. These advances have been complemented by the results of several large studies which have demonstrated decreased colorectal cancer mortality by the use of conventional screening tests, including the fecal occult blood test and sigmoidoscopy. Taken together, these developments have added powerful weapons for today's clinician in combating large bowel cancer. In this paper, screening techniques for average and high-risk groups for colorectal cancer will be reviewed. We have crossed the threshold and have entered the era in which colorectal cancer will be increasingly diagnosed in the asymptomatic, at-risk population with a resultant decreased morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=0030865707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030865707&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030865707

VL - 10

SP - 32

EP - 45

JO - Gastroenterology International

JF - Gastroenterology International

SN - 0950-5911

IS - 1

ER -